Bone marrow edema and osteitis in rheumatoid arthritis: the imaging perspective

Arthritis Research and Therapy

Volumn 14, Issue 5, 2012, Pages

  McQueen, Fiona M ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN;

B LYMPHOCYTE; BONE EROSION; BONE MARROW EDEMA; CALCIFICATION; CARTILAGE INJURY; COMPUTER ASSISTED TOMOGRAPHY; CORTICAL BONE; DISEASE ASSOCIATION; DOPPLER FLOWMETRY; HUMAN; IMAGING; LYMPHOCYTE DEPLETION; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEITIS; OSTEOPENIA; POWER DOPPLER ULTRASONOGRAPHY; PROGNOSIS; PROTEIN BLOOD LEVEL; PSORIATIC ARTHRITIS; REVIEW; RHEUMATOID ARTHRITIS; SACROILIITIS; SIGNAL DETECTION; SYNOVITIS; TRABECULAR BONE; ARTHRITIS, RHEUMATOID; BONE MARROW DISEASES; DIAGNOSTIC IMAGING; DISEASE COURSE; ECHOGRAPHY; EDEMA; PROCEDURES; RADIOGRAPHY; TRENDS;

ARTHRITIS, RHEUMATOID; BONE MARROW DISEASES; DIAGNOSTIC IMAGING; DISEASE PROGRESSION; EDEMA; HUMANS; MAGNETIC RESONANCE IMAGING; OSTEITIS; RADIOGRAPHY; ULTRASONOGRAPHY;

EID: 84867140337     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar4035     Document Type: Review

References (65)

1. Brook A, Corbett M. Radiographic changes in early rheumatoid disease. Ann Rheum Dis 1977, 36:71-73. 10.1136/ard.36.1.71, 1006633, 843114.
2. Resnick D, Gmelich JT. Bone fragmentation in the rheumatoid wrist: radiographic and pathologic considerations. Radiology 1975, 114:315-321.
3. Schett G, Firestein GS. Mr Outside and Mr Inside: classic and alternative views on the pathogenesis of rheumatoid arthritis. Ann Rheum Dis 2010, 69:787-789. 10.1136/ard.2009.121657, 20299352.
4. Wilson AJ, Murphy WA, Hardy DC, Totty WG. Transient osteoporosis: transient bone marrow edema?. Radiology 1988, 167:757-760.
5. Peterfy CG. Magnetic resonance imaging of the wrist in rheumatoid arthritis. Semin Musculoskelet Radiol 2001, 5:275-288. 10.1055/s-2001-17549, 11595971.
6. McQueen FM, Ostendorf B. What is MRI bone oedema in rheumatoid arthritis and why does it matter?. Arthritis Res Ther 2006, 8:222-225. 10.1186/ar2075, 1794510, 17169137.
7. Craig JG, Amin MB, Wu K, Eyler WR, van Holsbeeck MT, Bouffard JA, Shirazi K. Osteomyelitis of the diabetic foot: MR imaging-pathologic correlation. Radiology 1997, 203:849-855.
8. Poh YJ, Dalbeth N, Doyle A, McQueen FM. MRI bone oedema is not a major feature of gout unless there is concomitant osteomyelitis: ten year findings from a high prevalence population. J Rheumatol 2011, 38:2475-2481. 10.3899/jrheum.110477, 21965640.
9. Appel H, Loddenkemper C, Grozdanovic Z, Ebhardt H, Dreimann M, Hempfing A, Stein H, Metz-Stavenhagen P, Rudwaleit M, Sieper J. Correlation of histopathological findings and magnetic resonance imaging in the spine of patients with ankylosing spondylitis. Arthritis Res Ther 2006, 8:R143. 10.1186/ar2035, 1779434, 16925803.
10. McQueen F, Lassere M, Ostergaard M. Magnetic resonance imaging in psoriatic arthritis: a review of the literature. Arthritis Res Ther 2006, 8:207. 10.1186/ar1934, 1526607, 16569257.
11. Healy PJ, Groves C, Chandramohan M, Helliwell PS. MRI changes in psoriatic dactylitis - extent of pathology, relationship to tenderness and correlation with clinical indices. Rheumatology 2008, 47:92-95. 10.1093/rheumatology/kem315, 18077498.
12. Tan YM, Østergaard M, Doyle A, Dalbeth N, Lobo M, Reeves Q, Robinson E, Taylor WJ, Jones PB, Pui K, Lee J, McQueen FM. MRI bone oedema scores are higher in the arthritis mutilans form of psoriatic arthritis and correlate with high radiographic scores for joint damage. Arthritis Res Ther 2009, 11:R2. 10.1186/ar2586, 2688232, 19126234.
13. Zanetti M, Bruder E, Romero J, Hodler J. Bone marrow edema pattern in osteoarthritic knees: correlation between MR imaging and histologic findings. Radiology 2000, 215:835-840.
14. Taljanovic MS, Graham AR, Benjamin JB, Gmitro AF, Krupinski EA, Schwartz SA, Hunter TB, Resnick DL. Bone marrow edema pattern in advanced hip osteoarthritis: quantitative assessment with magnetic resonance imaging and correlation with clinical examination, radiographic findings, and histopathology. Skeletal Radiol 2008, 37:423-431. 10.1007/s00256-008-0446-3, 18274742.
15. Koenig H, Lucas D, Meissner R. The wrist: a preliminary report on high-resolution MR imaging. Radiology 1986, 160:463-467.
16. Jevtic V, Watt I, Rozman B, Kos-Golja M, Demsar F, Jarh O. Distinctive radiological features of small hand joints in rheumatoid arthritis and seronegative spondyloarthritis demonstrated by contrast-enhanced (Gd-DTPA) magnetic resonance imaging. Skeletal Radiol 1995, 24:351-355.
17. McQueen FM, Stewart N, Crabbe J, Robinson E, Yeoman S, Tan PL, McLean L. Magnetic resonance imaging of the wrist in early rheumatoid arthritis reveals a high prevalence of erosions at four months after symptom onset. Ann Rheum Dis 1998, 57:350-356. 10.1136/ard.57.6.350, 1752612, 9771209.
18. Peterfy CG, Countryman P, Gabriele A, Shaw T, Anisfeld A, Tsuji W, Olech E, Gaylis NB, Conaghan PG, Strand V, Dicarlo J. Magnetic resonance imaging in rheumatoid arthritis clinical trials: emerging patterns based on recent experience. J Rheumatol 2011, 38:2023-2030. 10.3899/jrheum.110418, 21885511.
19. Ostendorf B, Scherer A, Mödder U, Schneider M. Diagnostic value of magnetic resonance imaging of the forefeet in early rheumatoid arthritis when findings on imaging of the metacarpophalangeal joints of the hands remain normal. Arthritis Rheum 2004, 50:2094-2102. 10.1002/art.20314, 15248206.
20. Savnik A, Malmskov H, Thomsen HS, Graff LB, Nielsen H, Danneskiold-Samsøe B, Boesen J, Bliddal H. Magnetic resonance imaging of the wrist and finger joints in patients with inflammatory joint diseases. J Rheumatol 2001, 28:2193-2200.
21. Mundwiler ML, Maranian P, Brown DH, Silverman JM, Wallace D, Khanna D, Louie J, Furst DE, Weisman MH. The utility of MRI in predicting radiographic erosions in the metatarsophalangeal joints of the rheumatoid foot: a prospective longitudinal cohort study. Arthritis Res Ther 2009, 11:R94. 10.1186/ar2737, 2714150, 19545417.
22. McQueen FM, Stewart N, Crabbe J, Robinson E, Yeoman S, Tan PL, McLean L. Magnetic resonance imaging of the wrist in early rheumatoid arthritis reveals progression of erosions despite clinical improvement. Ann Rheum Dis 1999, 58:156-163. 10.1136/ard.58.3.156, 1752839, 10364913.
23. McQueen FM, Benton N, Perry D, Crabbe J, Robinson E, Yeoman S, McLean L, Stewart N. Bone edema scored on magnetic resonance imaging scans of the dominant carpus at presentation predicts radiographic joint damage of the hands and feet six years later in patients with rheumatoid arthritis. Arthritis Rheum 2003, 48:1814-1827. 10.1002/art.11162, 12847674.
24. Zheng S, Robinson E, Yeoman S, Stewart N, Crabbe J, Rouse J, McQueen FM. MRI bone oedema predicts eight year tendon function at the wrist but not the requirement for orthopaedic surgery in rheumatoid arthritis. Ann Rheum Dis 2006, 65:607-611. 10.1136/ard.2005.043323, 1798116, 16219706.
25. McQueen FM, Benton N, Crabbe J, Robinson E, Yeoman S, McLean L, Stewart N. What is the fate of erosions in early rheumatoid arthritis? Tracking individual lesions using × rays and magnetic resonance imaging over the first two years of disease. Ann Rheum Dis 2001, 60:859-868. 1753833, 11502613.
26. van der Heijde DM, van Riel PL, Nuver-Zwart IH, Gribnau FW, vad de Putte LB. Effects of hydroxychloroquine and sulphasalazine on progression of joint damage in rheumatoid arthritis. Lancet 1989, 1:1036-1038.
27. Benton N, Stewart N, Crabbe J, Robinson E, Yeoman S, McQueen FM. MRI of the wrist in early rheumatoid arthritis can be used to predict functional outcome at 6 years. Ann Rheum Dis 2004, 63:555-561. 10.1136/ard.2003.011544, 1755000, 15082487.
28. Haavardsholm EA, Bøyesen P, Østergaard M, Schildvold A, Kvien TK. Magnetic resonance imaging findings in 84 patients with early rheumatoid arthritis: bone marrow oedema predicts erosive progression. Ann Rheum Dis 2008, 67:794-800. 10.1136/ard.2007.071977, 17981915.
29. Hetland ML, Ejbjerg B, Hørslev-Petersen K, Jacobsen S, Vestergaard A, Jurik AG, Stengaard-Pedersen K, Junker P, Lottenburger T, Hansen I, Andersen LS, Tarp U, Skjødt H, Pedersen JK, Majgaard O, Svendsen AJ, Ellingsen T, Lindegaard H, Christensen AF, Vallø J, Torfing T, Narvestad E, Thomsen HS, Ostergaard M, . CIMESTRA study group MRI bone oedema is the strongest predictor of subsequent radiographic progression in early rheumatoid arthritis. Results from a 2-year randomised controlled trial (CIMESTRA). Ann Rheum Dis 2009, 68:384-390. 10.1136/ard.2008.088245, 18388160, CIMESTRA study group.
30. Hetland ML, Stengaard-Pedersen K, Junker P, Østergaard M, Ejbjerg BJ, Jacobsen S, Lottenburger T, Hansen I, Tarp U, Andersen LS, Svendsen A, Pedersen JK, Lauridsen UB, Ellingsen T, Lindegaard H, Pødenphant J, Vestergaard A, Jurik AG, Hørslev-Petersen K, . CIMESTRA study group Radiographic progression and remission rates in early rheumatoid arthritis - MRI bone oedema and anti-CCP predicted radiographic progression in the 5-year extension of the double-blind randomised CIMESTRA trial. Ann Rheum Dis 2010, 69:1789-1795. 10.1136/ard.2009.125534, 20444751, CIMESTRA study group.
31. Østergaard M, Peterfy C, Conaghan P, McQueen F, Bird P, Ejbjerg B, Shnier R, O'Connor P, Klarlund M, Emery P, Genant H, Lassere M, Edmonds J. OMERACT Rheumatoid Arthritis Magnetic Resonance Imaging Studies. Core set of MRI acquisitions, joint pathology definitions, and the OMERACT RA-MRI scoring system. J Rheumatol 2003, 30:1385-1386.
32. Hetland ML, Stengaard-Pedersen K, Junker P, Lottenburger T, Hansen I, Andersen LS, Tarp U, Svendsen A, Pedersen JK, Skjødt H, Lauridsen UB, Ellingsen T, Hansen GV, Lindegaard H, Vestergaard A, Jurik AG, Østergaard M, Hørslev-Petersen K, . CIMESTRA study group Aggressive combination therapy with intra-articular glucocorticoid injections and conventional disease-modifying anti-rheumatic drugs in early rheumatoid arthritis: second-year clinical and radiographic results from the CIMESTRA study. Ann Rheum Dis 2008, 67:815-822. 10.1136/ard.2007.076307, 17878209, CIMESTRA study group.
33. Palosaari K, Vuotila J, Takalo R, Jartti A, Niemelä RK, Karjalainen A, Haapea M, Soini I, Tervonen O, Hakala M. Bone oedema predicts erosive progression on wrist MRI in early RA--a 2-yr observational MRI and NC scintigraphy study. Rheumatology 2006, 45:1542-1548. 10.1093/rheumatology/kel137, 16670155.
34. Bøyesen P, Haavardsholm EA, van der Heijde D, Østergaard M, Hammer HB, Sesseng S, Kvien TK. Prediction of MRI erosive progression: a comparison of modern imaging modalities in early rheumatoid arthritis patients. Ann Rheum Dis 2011, 70:176-179. 10.1136/ard.2009.126953, 21068093.
35. Savnik A, Bliddal H, Nyengaard JR, Thomsen HS. MRI of the arthritic finger joints: synovial membrane volume determination, a manual vs a stereologic method. Eur Radiol 2002, 12:94-98. 10.1007/s003300100986, 11868082.
36. Duer-Jensen A, Hørslev-Petersen K, Hetland ML, Bak L, Ejbjerg BJ, Hansen MS, Johansen JS, Lindegaard HM, Vinterberg H, Møller JM, Østergaard M. Bone edema on magnetic resonance imaging is an independent predictor of rheumatoid arthritis development in patients with early undifferentiated arthritis. Arthritis Rheum 2011, 63:2192-2202. 10.1002/art.30396, 21484772.
37. Tamai K Yamato M, Yamaguchi T, Ohno W. Bone marrow oedema determined by MRI reflects severe disease status in patients with early-stage rheumatoid arthritis. Ann Rheum Dis 2006, 65(Suppl II):629. 1798129, 16192291.
38. Tamai M, Kawakami A, Uetani M, Takao S, Arima K, Iwamoto N, Fujikawa K, Aramaki T, Kawashiri SY, Ichinose K, Kamachi M, Nakamura H, Origuchi T, Ida H, Aoyagi K, Eguchi K. A prediction rule for disease outcome in patients with undifferentiated arthritis using magnetic resonance imaging of the wrists and finger joints and serologic autoantibodies. Arthritis Rheum 2009, 61:772-778. 10.1002/art.24711, 19479686.
39. Conaghan PG, O'Connor P, McGonagle D, Astin P, Wakefield RJ, Gibbon WW, Quinn M, Karim Z, Green MJ, Proudman S, Isaacs J, Emery P. Elucidation of the relationship between synovitis and bone damage: a randomized magnetic resonance imaging study of individual joints in patients with early rheumatoid arthritis. Arthritis Rheum 2003, 48:64-71. 10.1002/art.10747, 12528105.
40. Conaghan PG, Emery P, Østergaard M, Keystone EC, Genovese MC, Hsia EC, Xu W, Rahman MU. Assessment by MRI of inflammation and damage in rheumatoid arthritis patients with methotrexate inadequate response receiving golimumab: results of the GO-FORWARD trial. Ann Rheum Dis 2011, 70:1968-1974. 10.1136/ard.2010.146068, 3184239, 21784729.
41. Taylor PC, Steuer A, Gruber J, Cosgrove DO, Blomley MJ, Marsters PA, Wagner CL, McClinton C, Maini RN. Comparison of ultrasonographic assessment of synovitis and joint vascularity with radiographic evaluation in a randomized, placebo-controlled study of infliximab therapy in early rheumatoid arthritis. Arthritis Rheum 2004, 50:1107-1116. 10.1002/art.20123, 15077292.
42. Naredo E, Möller I, Cruz A, Carmona L, Garrido J. Power Doppler ultrasonographic monitoring of response to anti-tumor necrosis factor therapy in patients with rheumatoid arthritis. Arthritis Rheum 2008, 58:2248-2256. 10.1002/art.23682, 18668537.
43. Brown AK, Conaghan PG, Karim Z, Quinn MA, Ikeda K, Peterfy CG, Hensor E, Wakefield RJ, O'Connor PJ, Emery P. An explanation for the apparent dissociation between clinical remission and continued structural deterioration in rheumatoid arthritis. Arthritis Rheum 2008, 58:2958-2967. 10.1002/art.23945, 18821687.
44. Boesen M, Ellegaard K, Boesen L, Cimmino MA, Jensen PS, Terslev L, Torp-Pedersen S, Danneskiold-Samsøe B, Bliddal H. Ultrasound Doppler score correlates with OMERACT RAMRIS bone marrow oedema and synovitis score in the wrist joint of patients with rheumatoid arthritis. Ultraschall Med 2011,
45. Hodgson R, Grainger A, O'Connor P, Barnes T, Connolly S, Moots R. Dynamic contrast enhanced MRI of bone marrow oedema in rheumatoid arthritis. Ann Rheum Dis 2008, 67:270-272. 10.1136/ard.2007.077271, 17965120.
46. McQueen FM, Gao A, Ostergaard M, King A, Shalley G, Robinson E, Doyle A, Clark B, Dalbeth N. High grade MRI bone oedema is common within the surgical field in rheumatoid arthritis patients undergoing joint replacement and is associated with osteitis in subchondral bone. Ann Rheum Dis 2007, 66:1581-1587. 10.1136/ard.2007.070326, 2095325, 17491098.
47. McQueen F, Clarke A, McHaffie A, Reeves Q, Williams M, Robinson E, Dong J, Chand A, Mulders D, Dalbeth N. Assessment of cartilage loss at the wrist in rheumatoid arthritis using a new MRI scoring system. Ann Rheum Dis 2010, 69:1971-1975. 10.1136/ard.2009.127324, 20472589.
48. van der Heijde D. Erosions versus joint space narrowing in rheumatoid arthritis: what do we know?. Ann Rheum Dis 2011, 70(Suppl 1):i116-118. 10.1136/ard.2010.140525, 21339214.
49. Jimenez-Boj E, Nöbauer-Huhmann I, Hanslik-Schnabel B, Dorotka R, Wanivenhaus AH, Kainberger F, Trattnig S, Axmann R, Tsuji W, Hermann S, Smolen J, Schett G. Bone erosions and bone marrow edema as defined by magnetic resonance imaging reflect true bone marrow inflammation in rheumatoid arthritis. Arthritis Rheum 2007, 56:1118-1124. 10.1002/art.22496, 17393390.
50. Dalbeth N, Smith T, Gray S, Doyle A, Antill P, Lobo M, Robinson E, King A, Cornish J, Shalley G, Gao A, McQueen FM. Cellular characterisation of magnetic resonance imaging bone oedema in rheumatoid arthritis; implications for pathogenesis of erosive disease. Ann Rheum Dis 2009, 68:279-282. 10.1136/ard.2008.096024, 18765428.
51. McQueen F. A B cell explanation for autoimmune disease: the forbidden clone returns. Postgrad Med J 2012, 88:226-233. 10.1136/postgradmedj-2011-130364, 22328279.
52. McQueen FM, Dalbeth N. Predicting joint damage in rheumatoid arthritis using MRI scanning. Arthritis Res Ther 2009, 11:124. 10.1186/ar2778, 2787290, 19796371.
53. Hoff M, Haugeberg G, Odegård S, Syversen S, Landewé R, van der Heijde D, Kvien TK. Cortical hand bone loss after 1 year in early rheumatoid arthritis predicts radiographic hand joint damage at 5-year and 10-year follow-up. Ann Rheum Dis 2009, 68:324-329. 10.1136/ard.2007.085985, 18339664.
54. de Rooy DP, Kälvesten J, Huizinga TW, van der Helm-van Mil AH. Loss of metacarpal bone density predicts RA development in recent-onset arthritis. Rheumatology 2012, 51:1037-1041. 10.1093/rheumatology/ker435, 22258391.
55. Shimizu S, Shiozawa S, Shiozawa K, Imura S, Fujita T. Quantitative histologic studies on the pathogenesis of periarticular osteoporosis in rheumatoid arthritis. Arthritis Rheum 1985, 28:25-31. 10.1002/art.1780280105, 3966938.
56. Goldring SR, Gravallese EM. Mechanisms of bone loss in inflammatory arthritis: diagnosis and therapeutic implications. Arthritis Res 2000, 2:33-37. 10.1186/ar67, 129989, 11094416.
57. Døhn UM, Ejbjerg B, Boonen A, Hetland ML, Hansen MS, Knudsen LS, Hansen A, Madsen OR, Hasselquist M, Møller JM, Ostergaard M. No overall progression and occasional repair of erosions despite persistent inflammation in adalimumab-treated rheumatoid arthritis patients: results from a longitudinal comparative MRI, ultrasonography, CT and radiography study. Ann Rheum Dis 2011, 70:252-258. 10.1136/ard.2009.123729, 20980282.
58. McQueen F, Naredo E. The 'disconnect' between synovitis and erosion in rheumatoid arthritis: a result of treatment or intrinsic to the disease process itself?. Ann Rheum Dis 2011, 70:241-244. 10.1136/ard.2010.139535, 21233504.
59. Sato K, Takayanagi H. Osteoclasts, rheumatoid arthritis, and osteoimmunology. Curr Opin Rheumatol 2006, 18:419-426. 10.1097/01.bor.0000231912.24740.a5, 16763464.
60. Cohen SB, Dore RK, Lane NE, Ory PA, Peterfy CG, Sharp JT, van der Heijde D, Zhou L, Tsuji W, Newmark R, . Denosumab Rheumatoid Arthritis Study Group Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis: a twelve-month, multicenter, randomized, double-blind, placebo-controlled, phase II clinical trial. Arthritis Rheum 2008, 58:1299-1309. 10.1002/art.23417, 18438830, Denosumab Rheumatoid Arthritis Study Group.
61. Peterfy C, Emery P, Tak PP, Østergaard M, DiCarlo J, Otsa K, Navarro Sarabi F, Pavelka K, Preston K, Shaw T, Bagnard MA, Gabriele A. Rituximab (RTX) plus methotrexate (MTX) prevents bone erosion and joint space narrowing (jsn) and reduces synovitis, osteitis as shown on MRI: results from a randomised, placebo-controlled clinical trial on patients with rheumatoid arthritis (RA-score) [abstract]. Ann Rheum Dis 2011, 70(Suppl 3):152.
62. Tak PP, Rigby WF, Rubbert-Roth A, Peterfy CG, van Vollenhoven RF, Stohl W, Hessey E, Chen A, Tyrrell H, Shaw TM, . IMAGE Investigators Inhibition of joint damage and improved clinical outcomes with rituximab plus methotrexate in early active rheumatoid arthritis: the IMAGE trial. Ann Rheum Dis 2011, 70:39-46. 10.1136/ard.2010.137703, 20937671, IMAGE Investigators.
63. Boumans MJ, Thurlings RM, Yeo L, Scheel-Toellner D, Vos K, Gerlag DM, Tak PP. Rituximab abrogates joint destruction in rheumatoid arthritis by inhibiting osteoclastogenesis. Ann Rheum Dis 2012, 71:108-113. 10.1136/annrheumdis-2011-200198, 22072013.
64. Troum OM, Peterfy CG, Kaine JL, Chung CA, Olech E, Conaghan PG. Baseline CRP predicts early improvement in synovitis, osteitis, and erosion on MRI in RA patients treated with tocilizumab: results from the ACT-RAY MRI substudy. Arthritis Rheum 2010, 62(Suppl 10):120.
65. Peterfy C, Durez P, DiCarlo J, Becker JC, Vratsanos G, Overfield S, Qi K. Abatacept reduces osteitis and inhibits bone erosion in anti-CCP2 positive patients with synovitis at high risk of developing RA. Arthritis Rheum 2009, 60(Suppl 10):1690.